aspergillosis

Basilea to receive sales milestone payments from Astellas based on exceeding certain thresholds from the sales of antifungal Cresemba®

BASEL, 11-Dec-2018 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the sales of the antifungal Cresemba® (isavuconazole) by Astellas…

5 years ago